School of Medicine | University of Colorado



CURRICULUM VITAE

1. CURRENT POSITION

Viral N Shah, MD

Associate Professor of Medicine & Pediatrics

Barbara Davis Center for Diabetes Adult Clinic

University of Colorado Anschutz Campus

1775 Aurora Ct, Room M20-1318

Aurora, CO 80045

Phone: 303-724-8186

Fax: 303-724-6784

Email: viral.shah@cuanschutz.edu

2. EDUCATION

Year School/Institution Degree

1997-2002 Saurashtra University, M.P. Shah Medical College, India MBBS

2000-2003 Saurashtra University, M.P. Shah Medical College, India Internship

2004-2007 Saurashtra University, M.P. Shah Medical College, India MD

Internal Medicine Residency

2009-2012 Postgraduate Institute of Medical Education & Research, India DM

Fellowship in Endocrinology, Metabolism and Diabetes

5/2013-11/2013 Clinical and Research Observership, Barbara Davis Center for Diabetes Adult clinic, University of Colorado, Aurora, CO

3. ACADEMIC APPOINTMENTS

2003 - 2004 Instructor, Department of Medicine at C.U. Shah Medical College, India

2008 - 2009 Assistant Professor, Department of Medicine, Government Medical College, Bhavnagar, India

12/2013- 6/30/2020 Assistant Professor of Pediatrics & Medicine, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus School of Medicine, Tenure track

7/1/2020-Present Associate Professor of Pediatrics & Medicine, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus School of Medicine, Tenure track

4. HOSPITAL, GOVERNMENT OR OTHER PROFESSIONAL POSITIONS

7/2012 – 12/2012 Attending Endocrinologist, Indus Hospital, Mohali, India

1/2013 – 5/2013 Attending Endocrinologist, Wockardt Hospital, Bhavnagar, India

12/2013- Present Privileges at Children’s Hospital Colorado and University Colorado Hospital

12/2013-Present Research Privileges at CTRC and University of Colorado Hospital

5. HONORS, SPECIAL RECOGNITION AND AWARDS

1995. SSC Scholarship from Gujarat Government, India

1997. Merit Certificate, National Scholarship Scheme, Education Department,

Government of Gujarat, India

2001 Short-term Studentship, Indian Council of Medical Research, India

2001 Appreciation Certificate for Humanitarian Services rendered during earthquake, January 26, 2001 by Drug Bank Trust at M.P. Shah Medical College, Jamnagar, India

2001 Certificate of Merit in 14th IAP Pediatric Quiz, July 2001

2006 B. Braun Medical Trust Foundation Scholar Award, Clinical Medicine

2012 A.V. Gandhi Award for Excellence in Endocrinology, India

2012 Shree Satya Sai Youth Award for Humanitarian Work, Bhavnagar, India

2016-2017 T1D Exchange Steering Committee Member

2016-2018 President, American Associations of Physicians of Indian origin,

Colorado Chapter

2016 Highest patients’ recruitment award, Mini-Dose Glucagon study,

T1D Exchange Clinic Network Registry

2018 Outstanding recruitment in the T1D Exchange protocol “A study to assess

CGM profiles in healthy non-diabetic subjects”, T1D Exchange Clinic Network Registry

2018 Ad hoc Diabetes Technology subcommittee for American Diabetes

Association’s 79th scientific sessions Meeting Planning Committee

2018 Communication Director, Diabetes Technology Interest Group Leadership

Committee, American Diabetes Association

2019 Member, Disease State Network Committee (Diabetes and Bone and parathyroid disease) of American Association of Clinical Endocrinologist (AACE)

6. MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS

2010- Present Association of Physicians of India

2011- Present Endocrine Society of India

2011- Present Research Society for the Study of Diabetes in India (RSSDI)

2011- Present American Association of Clinical Endocrinologists (AACE)

2012- Present Indian Society for Bone and Mineral Research

2013- Present American Diabetes Association

2016- Present The Endocrine Society

2016- Present American Society of Bone and Mineral Research

7. COMMITTEE AND SERVICE RESPONSIBILITIES

Barbara Davis Center for Diabetes and University of Colorado

2013- 2017 In-Charge, monthly BDC Adult educational meeting (Journal Club). I was responsible for educational content and speakers within Adult clinic

2015- Member, BDC Citizenship Policy Committee. Chair: Paul Wadwa, MD.

The Committee prepared a draft of formal guidelines on good citizenship criteria for BDC.

2015- Member, BDC Faculty Appointment Policy Committee. Chair: Paul Wadwa, MD. The Committee prepared an appointment policy draft to align with the University of Colorado policy.

2017-Present Member, BDC Faculty Development Committee.

Chair: Judy Baxter, MA 2018, Janet Snell-Bergeon, PhD 2019

2017- Present Director, Bone Metabolism in Diabetes (BMD) Core Laboratory

2018-Present Director, Diabetes Dialog, an educational program for Adult Endocrinology Fellows

2018-Present Scholarly Oversight Committee (SOC) for Pediatric Endocrinology Fellow (Dr. Tommerdahl)

2020 Mentor, Women in Science, Technology, Engineering and Mathematics (WiSTEM)

Colorado State Service

2016- 2018 President, American Association of Physicians of Indian Origin (AAPI) Colorado Chapter

National Service

2015 Juvenile Diabetes Research Foundation (JDRF) “Non-Insulin Therapy” Grant Review Committee

2016-2017 T1D Exchange Steering Committee. Competitive. I was selected as one of the Six Steering Committee Members. I along with other steering committee members coordinated research activities at T1D Exchange Clinic Network Registry that is collaboration of more than 70 diabetes centers across the United States.

2016- Present “Older Adults Writing Committee and Working Group” and “Macrovascular Complications Writing Committee”, T1D Exchange Clinic Network Registry

2016- Present ADA Fellowship Grant Reviewer

2018-Present Ad hoc Member, Diabetes Technology subcommittee for American Diabetes Association’s 79th scientific sessions Meeting Planning Committee

2018-Present Communication Director, Diabetes Technology Interest Group Leadership

Committee, American Diabetes Association

2018-Present ASBMR annual meeting abstract reviewer

2018-Present ADA 79th scientific meeting abstract reviewer and selection committee

2019-Present Member, Disease State Network Committee (Diabetes and Bone and parathyroid disease) of American Association of Clinical Endocrinologist (AACE)

2019-2020 American College of Endocrinology self-assessment program (ASAP) Writing Committee Member

8. LICENSURE AND BOARD CERTIFICATION

2003- Present Gujarat Medical Council, India (G-33540, MBBS)

2008- Present Board Certification in Internal Medicine

(Medical Council of India, G-15054)

2012- Present Board Certification in Endocrinology, Diabetes and Metabolism

(Medical Council of India, 8230-PG2009)

2013-2015 Distinguished Foreign Teaching Physician license,

Colorado State Medical License (TDP.0041923)

2015- Present Colorado State Medical License (DR.0055426)

2018- Present ABIM Internal Medicine Board Certification (ABIM 409221)

2019- Present ABIM Endocrinology, Diabetes and Metabolism Certification

9. REVIEW AND REFEREE WORK

Journals

• Diabetes care

• Journal of Bone and Mineral Research (JBMR)

• Diabetologia

• Diabetic Medicine

• Bone

• Diabetes Technology and Therapeutics

• Indian Journal of Medical Research

• Indian Journal of Endocrinology and Metabolism

• Nutrients

• Calcified Tissue International

• Osteoporosis International

• Therapeutic Advances in Endocrinology and Metabolism

• BMC Endocrine Disorders

• Postgraduate Medicine

• Sensors

• Endocrine Practice

• Scientific Reports

• Endocrine Connections

• PLOS One

• Current Medical Research and Opinion

• European Endocrinology

• BMJ Open Diabetes Research & Care

• US Endocrinology

• Journal of Diabetes Mellitus

• Nutrition and Diabetes

• QJM: an international Journal of Medicine

• Diabetes, Obesity and Metabolism

• European Endocrinology

• Endocrinology, Diabetes & Metabolism Case Reports

• Therapeutic Advances in Endocrinology & Metabolism

• Journal of Pediatric Endocrinology

• Journal of Clinical Endocrinology & Metabolism (JCEM)

•

Abstract Reviewer

• 28th Annual Rocky Mountain Interprofessional Research & Evidence-Based Practice Symposium, Organized by University of Colorado Health, April 14-15, 2016

• Annual meetings of American Society of Bone and Mineral Research (2018- present)

• Annual meetings of American Diabetes Association (2018- present)

Grant Review

• Juvenile Diabetes Research Foundation (JDRF) “Non-Insulin Therapy” Grant Review Committee (2015)

• T1D Exchange Registry Pilot Grant Proposal reviews (2016-2017)

• ADA Fellowship Grant Reviewer (2016- present)

• Ministry of Health, NMRC: Diabetes Health Services Research Grant Application Reviewer (2017)

• ADA covid-19 and diabetes related grants (2020)

• NIDDK, ZDK1GRB-S (O1) study section meeting, X01 grant reviewer (2020)

Editor

• Editorial Board member, Endocrine Connections, an official publication of the Endocrine Society, UK (2010- Present)

• Editorial Board, Journal of Diabetes Research (2012- Present)

• Associate Editor, BMC Endocrine Disorders (2018-Present)

• Section Editor, Current Opinion Diabetes, Endocrinology and Metabolism, (2020- 2021)

10. INVITED LECTURES AND PRESENTATIONS

Local

10/2014 Barbara Davis Center for Diabetes Adult Clinic Journal Club: “Bone Mineral Density and Its Determinants in Type 1 Diabetes”

10/2015 Barbara Davis Center for Diabetes M& M meeting: “An Usual Cause of Diabetes Ketoacidosis”

2/2016 Diabetes Nurse Resource Meeting: “Case Studies- What’s New in Colorado”

10/2016 Advancing Diabetes Care through Technology Workshop in partnership with JJDI: “Expectations of Continuous Glucose Monitoring Data Management”

1/2017 School of Medicine, Division of Endocrinology weekly research conference: “Bone Health in Type 1 Diabetes”

3/2017 Bone Think Tank Monthly meeting: “Bone Health in Type 1 Diabetes

4/2017 Barbara Davis Center for Diabetes Research in Progress (RIP) monthly meeting: “Bone Health in Type 1 Diabetes: What do we know so far?”

6/2017 Barbara Davis Center for Diabetes, Pediatric Endocrine Fellow Monthly Meeting: “Bone Health in Type 1 Diabetes”

7/2017 Chinese Delegation Program at the Barbara Davis Center for Diabetes (a pre ATDC annual meeting): “Update on Basal Insulin”

11/2018 School of Medicine, Division of Endocrinology Monthly Diabetes Conference: Bone Health in Type 1 Diabetes: What You Should Know”

1/2019 Barbara Davis Center for Diabetes, Pediatric Endocrine Fellow Monthly Meeting: “Bone Health in Type 1 Diabetes”

Regional

6/2014 ‘Reach U Teach’ patient education program by Juvenile Diabetes Research Foundation: “Complications of Type 1 Diabetes”

4/2018 Achieving Diabetes Outcomes with Technology- Type 1 diabetes educational event organized by the Medtronic Diabetes: “Why Diabetes Technology?”

5/2020 “Is human insulin (Walmart insulin) right for you?” Online community event organized by the Children Diabetes Foundation.

National

4/2016 Type 1 Diabetes Exchange Clinic Network Annual Meeting, Tampa, Florida: “Human Factors Associated with Insulin Pump and Continuous Glucose Monitor Discontinuation among Adults with Type 1 Diabetes”

4/2017 Type 1 Diabetes Exchange Clinic Network Annual Meeting, Tampa, Florida: “Sex differences in Diabetes Care, Comorbidies and Complications in Adults with T1D”

9/2017 School of Medicine, Division of Endocrinology, Diabetes and Metabolism Grand Round, Henry Ford Hospital, Detroit: “Bone Health in Type 1 diabetes”

3/2018 Type 1 Diabetes Exchange Clinic Network Annual Meeting, Tampa, Florida: “Macrovascular/Cardiovascular Complications over Time”

7/2018 Diabetes Dialog- Diabetes Update for Endocrine Fellows, Denver, Colorado: “Role of Glucose Monitoring in Type 1 Diabetes”

7/2018 Diabetes Dialog- Diabetes Update for Endocrine Fellows, Denver, Colorado: “Review of CGM and Pump Downloads”

7/2018 Diabetes Dialog- Diabetes Update for Endocrine Fellows, Denver, Colorado: “Case-Based Discussion for Type 1 Diabetes Management”

10/2018 Advancing Care through Technology in Insulin Requiring Patients with Diabetes by Johnson & Johnson Diabetes Institute: “Future technologies for multiple daily injections”

10/2018 Advancing Care through Technology in Insulin Requiring Patients with Diabetes by Johnson & Johnson Diabetes Institute: “Role of Continuous Glucose Monitoring in Diabetes Management”

3/2019 School of Medicine, Joint Grand Round by the Division of Endocrinology and Indiana Center for Musculoskeletal Health, University of Indianapolis: “Bone Health in Type 1 Diabetes”

8/2020 The WISDM of using RT-CGM in Seniors, Virtual meeting, Oregon

10/2020 Endocrine Grand Rounds, Wake Forest Baptist Health: “Bone Health in Type 1 diabetes”

10/2020 School of Medicine, Division of Endocrinology, Diabetes and Metabolism Grand Round, Henry Ford Hospital, Detroit: “Understanding Time-in-Range for Management of Diabetes”

International

11/2014 Endocrine Society of India Annual meeting (ESICON 2014), Chandigarh, India: “Mobile Technologies in Managing Diabetes”

11/2014 Endocrine Society of India Annual meeting (ESICON 2014), Chandigarh, India: “Setting up an Insulin Pump Clinic”

11/2014 Endocrine Society of India Annual meeting (ESICON 2014), Chandigarh, India: “Continuous Glucose Monitoring in the Management of Diabetes”

1/2016 Association of Physicians of India Annual Meeting (APICON 2016), Hydrabad, India: “Mobile Technologies in Managing Diabetes”

6/2017 Annual Meeting of American Society of Sport Medicine (ASCM), Denver, Colorado: “Bone Health in Type 1 Diabetes”

10/2018 A CME educational program held in conjunction with American Diabetes Association’s 78th scientific sessions by CogniMed, Orlando, Florida: “Continuous Glucose Monitoring Categories”

1/2019 Study of Improved Glucose Monitoring and Assessment (SIGMA) advisory panel presentation, Scottsdale, Arizona: “CGM in the clinical practice”.

4/2019 A CME educational program held in conjunction with American Association of Clinical Endocrinologists (AACE) by CogniMed, Los Angeles, California: “Challenging the Paradigm:  Introducing CGM Early in Diagnosis”

6/2019 Diabetes Technology Interest Group at American Diabetes Association 79th session, San Francisco, California: “Not the right device?”

7/2019 Practical Ways to Achieve Targets in Diabetes Care (ATDC) annual meeting, Keystone, Colorado: “Advances in Continuous Glucose Monitoring”

5/2020 MedscapeLIVE! Symposium: "Completing the Picture with Clinical Use of Real-Time CGM"

1/2020 Swasthyacon, Annual meeting of diabetes in Ahmedabad, India: “Time-in-Range and Glycemic Variability: New Glycemic Metrics to Consider”

1/2020 Swasthyacon, Annual meeting of diabetes in Ahmedabad, India: “Tips for Insulin Pump use in Diabetes”

1/2020 Insulin Nation, Primary Care Educational Event, Ahmedabad, India: “Beyond A1c”.

6/2020 Diabetes Technology Interest Group at American Diabetes Association 80th Scientific Session: “Interpreting Time-In-Range in pregnancy”. Virtual meeting.

6/2020 Diabetes Technology Interest Group forum at American Diabetes Association 80th Scientific Session: “Personal Perspectives on remote monitoring in the post-COVID environment”.

7/2020 Hyperglycemia in Pregnancy (HIP) conference, India: “Continuous glucose monitoring in management of diabetes during pregnancy”

9/2020 2020 Peking University Diabetes Forum, Virtual meeting, China:” remote monitoring of diabetes management in covid-19 era”

9/2020 1st Annual Conference of RSSDI on a Digital Platform, virtual meeting, India: “Managing diabetes: Think beyond A1c”

11. TEACHING RECORD

Medical Student Presentations

11/2015-1/2016 Digestive, Endocrine, and Metabolic System; Small group facilitator

(2 sessions)

11/2016-1/2017 Digestive, Endocrine, and Metabolic System; Small group facilitator

(5 sessions)

11/2017-1/2018 Digestive, Endocrine, and Metabolic System; Small group facilitator

(5 sessions)

Department of Pediatrics, Division of Endocrinology/ Pediatric Endocrine Fellows Presentation

6/2017 Barbara Davis Center for Diabetes, Pediatric Endocrine Fellow Monthly Meeting: “Bone Health in Type 1 Diabetes”

1/2019 Barbara Davis Center for Diabetes, Pediatric Endocrine Fellow Monthly Meeting: “Bone Health in Type 1 Diabetes”

Other teaching Endeavors

2014-Present Mentoring Medical Students, Nursing students, Endocrine Fellows, and junior faculties

2016-Present Foundations of Doctoring Preceptor

2018 Master of Public Health (MPH) Capstone Project (Daniel Tyler)

Administrative Positions

2014- 2016 In-charge, International Student Delegation Education Program, Barbara Davis Center for Diabetes Adult Clinic. Every year in the month of June and July, BDC Adult Clinic used to invite 2-3 Medical doctors from China to visit BDC and exchange the clinical and research in the area of type 1 diabetes [program ended in 2017].

2018-Present Director, Diabetes Dialog- Diabetes Update for Endocrine Fellows. Up to 10 fellows from different institutions across the US are invited for this 3 days educational program on diabetes and diabetes technologies.

12. GRANT SUPPORT

CURRENT RESEARCH SUPPORT

1. K23AR075099, Shah (PI) 4/10/2019–3/31/2023

NIH/NIAMS

Volumetric bone density, geometry, strength, and bone tissue material properties in type 1 diabetes.

Goal of this project is to evaluate bone structural and material quality in postmenopausal women with type 1 diabetes compared to postmenopausal women without diabetes.

2. R01DK122554-01 Shah (PI) 9/13/2019–8/31/2024

Bone Health in Adults with Type 1 Diabetes

Goal of this project is to evaluate bone structural and material quality over 3-year period to identify factors associated with compromised bone quality in adults with type 1 diabetes compared to adults without diabetes

Role: Principal Investigator

3. NovoNordisk Shah (PI) 10/21/2019–10/19/2020

Successful Transition from Insulin Pump to Multiple Daily Injections Using Insulin Degludec in Adults with Type 1 Diabetes (TRANSITION Clinical Trial)

Goal of this project is to evaluate strategies for insulin pump to multiple daily injection transition in adults with type 1 diabetes.

This is an investigator-initiated study

Role: Principle Investigator

4. NN 9535- 4352 Shah (Site PI) 6/1/2019–6/30/2023

NovoNordisk

Long-term effects of semaglutide on diabetic retinopathy in patients with type 2 diabetes (FOCUS)

The goal of this clinical trial is to establish the safety of semaglutide in regards to development of or worsening of diabetic retinopathy in patients with type 2 diabetes.

Role: Site Principal Investigator

5. Insulet Shah (Site PI) 12/6/2019-10/30/2020

Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients with Type 1 Diabetes

The goal of this clinical trial is to evaluate safety and efficacy of new omnipod hybrid closed-loop system in patients with type 1 diabetes.

Role: Site Principal Investigator

6. 25A9201 Shah (Site PI) 12/6/2019-10/30/2020

Abbott

Validation of individualized A1c from CGM based glycemic profile and point-of-care A1c

Goal of this grant is to validate mathematical formula developed by Dr. Yogjin Xu at Abbott using CGM profile and point of care A1c of 100 subjects with type 1 diabetes

Role: Principal Investigator

7. Eli-Lilly McQueen (PI) 6/1/2020-5/30/2021

Impact of Connected Care on Outcomes utilizing Continuous Glucose Monitoring (CGM), Electronic Medical Records (EMR) and Claims Data

Role: Co-investigator

COMPLETED RESEARCH SUPPORT

1. Jaeb Center/ T1D Exchange Gonzalez (PI) 07/2017-11/2018

Young Adult Racial Disparities in Type 1 Diabetes (YARDD)

The purpose of this study is to identify factors associated with poor health outcomes and care 55 experiences in low-income minority YA with T1D

Role: Co-investigator

2. Jaeb Center/ T1D Exchange Miller (PI) 06/2017-01/2019

Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) Study

It is a randomized clinical trial to assess the efficacy and safety of continuous glucose monitoring in individuals 60 years old or older o with type 1 diabetes.

Role: Site Principal Investigator and Steering Committee Member

3. T1D Exchange program Shah (PI) 11/2017-12/2018

Acute Effect of Exogenous Insulin on Markers of Bone Metabolism

This is a pilot, investigator initiated T1D Exchange grant to evaluate the acute effect of hyperinsulinemia on bone turnover markers from the blood samples collected during hyperinsulinemic euglycemic clamp of Beta Cell Function study.

4. Sanofi EFC15081 Shah (Site PI) 8/2017-12/2018

Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog/ NovoRapid in Adults patients with Diabetes Mellitus Also using Insulin Glargine, with a 6-month Safety Extension Period.

Goal is this clinical trial is compare investigational short acting insulin with standard Novolog, short acting insulin in patients with type 1 diabetes.

5. Jaeb Center for Health Research Nadeau (PI) 11/2015 - 10/2016

Beta cell function and glucose counter regulation in the progression of type 1 diabetes

The goal of this study is to investigate beta cell function and counter regulatory hormones at different stages of type 1 diabetes by performing insulin clamp studies.

Role: Co-Investigator

6. Jaeb Center for Health Research Haymond (PI) 10/2015-06/2016

A pilot study to assess the Efficacy and safety of Mini-dose glucagon for the treatment of non-severe hypoglycemia in adults with type 1 diabetes- T1D Exchange Multicentric study.

To evaluate the safety and efficacy of low dose glucagon in prevention of mild to moderate hypoglycemia.

Role: Site Principal Investigator

7. Jaeb Center for Health Research Aleppo (PI) 02/2015-09/2016

A Randomized Trial Comparing Continuous Glucose Monitoring with and without Routine Blood Glucose Monitoring in Adults with Type 1 Diabetes

To study whether insulin administration based on CGM glucose is safe or not.

Role: Site Principal Investigator

8. Center for Women’s Health Research Shah (PI) 05/2016- 07/2017

Bone and Vascular health in Postmenopausal women with Type 1 diabetes

The goal of this study is to evaluate the association between areal bone density at lumbar spine and femoral neck and vascular calcification among postmenopausal patients with type 1 diabetes compared to age matched postmenopausal women without diabetes.

9. UCAMC CO CCTSI Microgrant Shah (PI) 05/2016- 07/2017

Bone and Vascular health in Postmenopausal women with Type 1 diabetes

CCTSI microgrant is to support the laboratory expenses for the bone and vascular health in postmenopausal women with type 1 diabetes study.

10. 16GRU2653, NIH/NIDDK Snell-Bergeon & Shah (PI) 10/01/16-07/31/17

The Role of Hormones in the Premature Vascular and Bone Disease in Women with Type 1 Diabetes

The purpose of this feasibility grant is to investigate the common risk factors, including sex hormone levels and reproductive history, between premature vascular and bone complications in women with type 1 diabetes.

Role: CO-PI

11. Jaeb Center for Health Research Shah (Site PI) 08/2016- 06/2017

Quality of Life in Type 1 Diabetes

The aim of this study is to validate a quality of life questionnaire in type 1 diabetes patients.

12. LPS14587, Sanofi Shah (Site PI) 08/2016-07/2017

A Randomized, Active-Controlled, Parallel Group, 16-Week Open Label Study

Comparing the Efficacy and Safety of the Morning Injection of Toujeo (Insulin Glargine-U300) Versus Lantus in Patients with Type 1 Diabetes Mellitus

13. JDRF/ Jaeb Center Hovarka (PI) 03/2017- 11/2017

Home Testing of Day and Night Closed Loop with Pump Suspend Feature (APCam11)

Multicenter, multinational randomized controlled trial to evaluate the safety and efficacy of day and night time closed-loop system at home in free living condition.

Role: Site Principal Investigator

14. EyeNuk Shah (Site PI) 02/2018- 07/2018

Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

The study is aimed to compared an undilated eye exam as a retinopathy screening using EyeArt instrument with dilated standard of care eye examination

15. Jaeb Center/ T1D Exchange Tamborlene (PI) 07/2017- 10/2018

A study to assess continuous glucose sensor profile in healthy non-diabetic subjects.

The goal of this project is to define normal rage for CGM parameters such as time in range. This normative data can be useful to serve as a reference range for artificial pancreas technologies.

Role: Site Principal Investigator and protocol-Co-Chair

16. TTP399-203 Shah (Site PI) 7/15/2019-12/30/2019

vTv Therapeutics

A Multi-Center, Randomized, Double-Blind, Parallel-Group, Multiple-Dose Adaptive Study Assessing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of TTP399 in Patients with Type 1 Diabetes Mellitus

Role: Site Principal Investigator

17. DK101108, UC4DK101108-01 (Doria, PI; Polsky, sitePI) 2/2014-06/2019

NIH/NIDDK

Prevention of Early Renal Loss in type 1 diabetes (PERL) study ‘A multicenter clinical trial of allopurinol to prevent GFR loss in type 1 diabetes

The goal of this study is to see whether a medication called allopurinol may help prevent loss of kidney function among people with type 1 diabetes

Role: Co-investigator

18. FEC 15178 Shah (Site PI) 4/1/2019-3/30/2020

Sanofi

Randomized, Open label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog® versus Continuous Use of NovoLog in Patients with Type 1 Diabetes Mellitus also Using Insulin Glargine

This is a three month randomized control trial to evaluate safety and immunogenicity of SAR341402 compared to Novolog in adults with type 1 diabetes.

Role: Site Principal Investigator

19. MYL-1601D-3001 (Shah, site PI) 4/1/2019- 5/30/2020

Mylan/GmbH A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with Novolog in Type 1 Diabetes Mellitus Patients.

Goal of this study is to establish safety and efficacy of investigational biosimilar insulin (MYL-1601D) compared to Novolog insulin in patients with type 1 diabetes

Role: Site principal investigator

13. BIBLIOGRAPHY

Publications in Peer-Reviewed Journals (in chronological order)

Manuscripts resulting from students/fellows mentoring work are marked with an asterisk (**)

1. Shah BK, Shah VN. Antimicrobial use by the department of obstetrics and gynecology of a tertiary care hospital: analysis for rationality. Indian journal of obstet gynecol 2004; 54: 387-392.

2. Shah VN, Verma PB, Tripathi CB. Knowledge attitude practice regarding tobacco consumption among college students of Bhavnagar city (Gujarat). Indian journal of community medicine 2005:30:39-40.

3. Shah VN, Karavadara NR, Shah DS, Shah BK. Gatifloxacin induced prolongation of QTc interval. Indian journal of pharmacology 2006: 38(1): 60-61.

4. Gupta BD, Hapani JH Shah VN. Current trend of poisoning in Jamnagar: An experience of tertiary care teaching hospital. JIAFM 2006; 28(3): 90-92.

5. Gupta BD, Shah VN. Clinical profiles, treatment and complications of snake bites: A one-year retrospective study. JIAFM 2006; 28:102-104.

6. Shah VN, Hirani M, Oza JJ. Polycystic liver and kidney. J Assoc Physicians India. 2007; 55:155-6. [PMID: 17571751]

7. Shah VN, Kamdar PK, Shah NS. Assessing the knowledge, attitudes and practice of type 2 diabetes among patients of Saurashtra region (Gujarat)- Int J of Diabetes in Dev Ctries 2009; 29(3): 118-122. [PMID 20165648]

8. Shah VN, Mehta M N, Santwani P.M. A rare suspected case of Congenital Dyserythropoietic Anaemia type II. Journal of Clinical and Diagnostic Research [serial online] 2008 April [cited: 2009 Feb 20 ]; 2:757-759.

9. Shah VN, Baxi S, Vyas T. Severe myocardial depression in a case of aluminum phosphide poisoning: clinical, electrocardiograhic and histopathological correlation. Indian J Crit Care Med. 2009; 13:41-3.[PMID:19881181]

10. Shah VN, Patel T. “A Case of Malabsorption Syndrome (MAS) Due To Tropical Sprue.” Journal of Clinical and Diagnostic Research [serial online] 2009 April [cited: 2009 Jun 19]; 3:1445-1448.  

11. Kamdar P K, Shah VN. A Probable Case Of Craniodiaphyseal Dysplasia- A Rare Entity. Journal of Clinical and Diagnostic Research [serial online] 2009 June [cited: 2009 Jun 19]; 3:1573-1576.

12. Shah VN. Image In Medicine- Laurence-Moon Bardet-Biedl Syndrome. Journal of Clinical and Diagnostic Research [serial online] 2009 April [cited: 2009 Jun 19]; 3:1479-1479.

13. Shah VN, Shah CJ, Shah BK. Residency Training Programme- Appraisal by Residents. Journal of Health Management, 2010; 12(1):65-71.

14. Shah V N, Sanmukhani J. Statins: cost analysis in Indian scenario from eight major clinical trials. J Postgrad Med. 2010; 56: 196-200.[PMID:20739765]

15. Sanmukhani J, Shah VN, Baxi S, Tripathi CB. Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report. BJCP 2010; 69(6): 703-704. [PMID:20565463]

16. Santosh R, Bhansali A, Shah V et al. Primary Hyperparathyroidism with Unilateral Proptosis. BMJ Case Reports 2010: published online 8 February 2010, doi:10.1136/bcr.09.2009.2297. [PMID:22315641]

17. Shah VN, Sanmukhani J. Five Cases of Jatropha curcas poisoning. J Assoc Physicians India 2010; 58:245-246. [PMID:21046881]

18. Gupta BD, Chatterjee SS, Shah VN. Mass Illness due to Datura Poisoning: A Case Report. Journal of the Indian Society of Toxicology 2010; 6 (1): Online.

19. Bhadada SK, Bhansali A, Shah VN, Behera A, Ravikiran M, santosh R. High prevalence of cholelithiasis in primary hyperparathyroidism: A retrospective analysis of 120 cases. Indian J Gastroenterol 2011; 30: 100-101. [PMID: 21626228]

20. Bhadada SK, Bhansali A, Shah VN, Rao DS. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med J. 2011;52:890-3. [PMID: 22159932]

21. Shah V, Shah BK, Vadera B, Acharya H.K. Clinical Scoring System to Predict Malarial Fever: A Prospective Study. IJMEDPH 2011;1(2), DOI: 10.5530/ijmedph.2.2011.7

22. Bhansali A, Ajithkumar B V, Walia R, Rajwanshi A, Shanmugasundar G, Shah V. Vanishing adrenal mass. BMJ Case Reports Published 1 January 2011;published online 24 March 2011, doi:10.1136/bcr.01.2011.3757

23. Dutta P, Bhansali A, Shah VN, Walia R, Bhadada SK, Paramjeet S, Pathak A, Mukherjee KK, Khandelwal N. Pituitary metastasis as a presenting manifestation of silent systemic malignancy: A retrospective analysis of four cases. Indian J Endocrinol Metab. 2011;15:S242-5. [PMID:22029031]

24. Bhadada SK, Santosh R, Bhansali A, Varshney S, Shah VN, Gill KD. Do we need to do the calcium profile in the fasting state and without a tourniquet? Natl Med J India. 2011 Jan-Feb;24(1):54-5. Comment in Natl Med J India. 2011 May-Jun;24(3):186-7; author reply 187. [PMID21608365]

25. INdian DIabetes Consortium. INDICO: the development of a resource for epigenomic study of Indians undergoing socioeconomic transition. Hugo J. 2011 December; 5(1-4): 65–69. [PMID:23205164]

26. Rai S, Bhadada SK, Rattan V, Bhansali A, Rao DS, Shah V. Oro-mandibular manifestations of primary hyperparathyroidism. Indian J Dent Res. 2012; 23(3):384-7.[PMID:23059578]

27. Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 2012;58:107-11. [PMID: 22718053]

28. Bhadada SK, Agrawal A, Shah VN, Bhansali A, Behera A, Bhattacharya A, Nahar U. Pulmonary function tests in patients with primary hyperparathyroidism. Indian J Endocr Metab 2012;16:414-6. [PMID: 22629510]

29. Dutta P, Das S, Bhansali A, Bhadada S K, Rajesh B V, Reddy K S, Vaiphei K, Mukherjee KK, Pathak A, Shah V N. Congestive heart failure in acromegaly: A review of six cases. Indian J Endocrinol Metab. 2012; 16: 987-90. [PMID: 23226648]

30. Parvez N, Dutta P, Ray P , Shah VN, Prashad M, Khandelwal N, Kaman L, Bhansali A. Microbial profile and utility of soft tissue, pus and bone cultures in diagnosing diabetic foot infections. Diabetes Technol Ther. 2012; 14(8);669-74. [PMID:22690924]

31. Gupta Y, Bhadada SK, Shah VN, Upreti V, Bhansali A, Jain S, Khurana D, Kalara N. Carotid intima media thickness in patients with sporadic idiopathic hypoparathyroidism: a pilot study. Endocr J. 2012; 59(7): 555-9. [PMID: 22481143]

32. Shah VN, Premkumar A, Walia R, Kumar S, Nahar U, Bhansali A. Large but benign adrenal mass: Adrenal oncocytoma. Indian J Endocr Metab 2012;16:469-71. [PMID:22629525]

33. Cheema BS, Iyengar S, Ahluwalia TS, Kohli HS, Sharma R, Shah VN, Bhansali A, Khullar M. Association of an Osteopontin gene promoter polymorphism with susceptibility to Diabetic nephropathy in Asian Indians. Clin Chim Acta. 2012; 413:1600-4. [PMID: 22584029].

34. Dutta P, Mukherjee KK, Chaudhary PK, Masoodi S R, Anand S, Pathak A, Shah VN, Mathuriya SN. Pituitary dysfunction in survivors of spontaneous subarachnoid hemorrhage of anterior communicating artery and middle cerebral artery aneurysms: Neurol India 2012; 60 (4): 390-4. [PMID 22954974]

35. Cheema BS, Kohli HS, Sharma R, Shah VN, Bhansali A, Khullar M. ACE Variants Interact with the RAS Pathway to Confer Risk and Protection against Type 2 Diabetic Retinopathy. Journal of Diabetes Investigation 2013; 4(1): 103-104. [PMID: 24843639]

36. Varshney S, Bhadada SK, Nahar U, Shah VN, Bhansali A, Behera A. Chief cell and clear cell parathyroid adenoma does not influence clinical and biochemical expression of the sporadic primary hyperparathyroidism. Endocrine. 2013; 43 (2): 440-3. [PMID 23055014]

37. Shah VN, Cheema BS, Sharma R, Khullar M, Kohli HS, Ahluwalia TS, Mohan V, Bhansali A. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Mol Cell Biochem. 2013; 372: 191-8.[ PMID 23081748]

38. Tabassum R, Chauhan G, Dwivedi OP, Mahajan A, Jaiswal A, Kaur I, Bandesh K, Singh T, Mathai BJ, Pandey Y, Chidambaram M, Sharma A, Chavali S, Sengupta S, Ramakrishnan L, Venkatesh P, Aggarwal SK, Ghosh S, Prabhakaran D, Srinath RK, Saxena M, Banerjee M, Mathur S, Bhansali A, Shah VN, Madhu SV, Marwaha RK, Basu A, Scaria V, McCarthy MI; DIAGRAM; INDICO, Venkatesan R, Mohan V, Tandon N, Bharadwaj D. Genome-wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21. Diabetes. 2013; 62 (3): 977-86.[PMID 23209189]

39. Lata K, Dutta P, Sridhar S, Rohilla M, Grv P, Srinivasan A, Shah V, Bhansali A. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case control study. Endocr Connect 2013;2: 118-124. [PMID:23802061]

40. Dutta P, Premkumar A, Chakrabarti A, Shah VN, Behera A, Deepankar De, Rudramurthy SM, Bhansali A. Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: A case report and review of literature. Mycopathologia 2013 ;176:225-32 [PMID:23813152]

41. Shah VN, Ganatra PJ, Kamdar P, Parikh R, Shah N. Coexistence of Gonadal dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome in 46, XX female: A case report and review of literature. Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S274-7. [PMID: 24251185]

42.  Dutta P, Shah VN. Pretibial myxedema mimicking elephantiasis. International Journal of Case Reports and Images 2013;4(12):695–697. doi:10.5348/ijcri-2013-12-413-CR-7

43. Shah VN, Moser E, Blau A, Dhingra M, Garg SK. Future of basal Insulin. Diabetes Technol Ther. 2013 Sep;15(9):727-32. [PMID: 23965036]

44. Shah VN, Cheema BS, Kohli HS, Sharma R, Khullar M, et al. Endothelial Nitric Oxide Synthase Gene Polymorphism and the Risk of Diabetic Neuropathy in Asian Indian Patients with Type 2 Diabetes. J Diabetes Metab 2013; 4:243. doi: 10.4172/2155-6156.1000243

45. Garg SK, Michels AW, Shah VN. Use of non-insulin therapies for type 1 diabetes. Diabetes Technol Ther. 2013 Nov;15(11):901-8.[PMID: 24131372]

46. Dutta P, Agrawal A, Gogate Y, Nahar U, Shah VN, Singla M, Khandelwal N, Bhansali A. Non-islet cell tumor-induced hypoglycemia: A report of 5 cases and brief review of literature. Endocrinol Diabetes Metab Case Rep. 2013; 2013: 130046. [PMCID: PMC3922193]

47. Cheema BS, Kohli HS, Sharma R, Shah VN, Iyengar S and Khullar M: RAS Gene Polymorphisms and Renal Responsiveness to RAS Inhibition Therapy in Type 2 Diabetic Asian Indians. J Pharmacogenomics Pharmacoproteomics 2013; 4:114. doi: 10.4172/2153-0645.1000114

48. Shah VN, Bhadada SK, Bhansali A, Behera A, Bhattacharya A, Nahar U, Bhasin D, Vadera B. Effect of gender, biochemical parameters and parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism. Indian J Med Res. 2014 Feb;139:279-84. [PMID:24718404]

49. Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR. Changes in clinical and biochemical presentations of primary hyperparathyroidism in India over 20 years. Indian J Med Res. 2014 May;139(5):694-9. [PMID:25027078]

50. Shah VN. ANCA positive vasculitis in a patient with nodular Graves' disease caused by carbimazole. Thyroid Res Pract 2014;11:121-3.

51. Garg SK, Shah VN. Newer treatment options in management of diabetes- Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S119-27. [PMID:24479593]

52. Dheon P. Shah V N. Type 1 Diabetes and Osteoporosis: A Review of Literature. Indian J Endocrinol Metab. 2014 Mar-Apr; 18(2): 159–165. [PMID: 24741510]

53. Aggarwal N, Suri V, Singla R, Chopra S, Sikka P, Shah V, bhansali A. Pregnancy outcome in hyperthyroidism: A case-control study. Gynecol Obstet Invest. 2014;77(2):94-9. [PMID: 24481256]

54. Shah VN, Shah C S. Bhadada SK, Rao DS. Effects of vitamin D replacement in patients with primary hyperparathyroidism and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: A meta-analysis and review of literature. Clin Endocrinol (Oxf). 2014 Jun;80(6):797-803. [PMID:24382124]

55. Shah VN, Shoskes A, Tawfik B, Garg S.K. Closed-Loop System in the Management of Diabetes: Past, Present, and Future. Diabetes Technol Ther. 2014 ;16:477-90 [PMID:25072271]

56. Shah V N. Comment: Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2014 Jan-Mar;60(1):95 [PMID:24625956]

57. Shah VN. Cheema B, et al. Risk factors for proteinuria and renal insufficiency in Asian Indian patients with type 2 diabetes. International Journal of Diabetes in Developing Countries. 2015; 35: 554-558. Available at

58. Sooragonda B, Bhadada SK, Shah VN, Malhotra P, Ahluwalia J, Sachdeva N,. Effect of vitamin D replacement on hemoglobin concentration in subjects with iron deficiency anemia and concurrent vitamin D deficiency: A randomized single blind placebo-controlled trial. Acta Haematol. 2015;133(1):31-5. [PMID: 25012612]

59. Shah VN, Mohan V. Diabetes in India: What is different? Curr Opin Endocrinol Diabetes Obes. 2015; 22:283-9. [PMID: 26087335]

60. Shah VN, Garg SK. Managing diabetes in the digital age. Clin Diabetes Endocrinol. 2015 Dec 1;1:16. doi: 10.1186/s40842-015-0016-2. [PMID:28702234]

61. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 Diabetes and Risk for Fracture: Meta-analysis and Review of the Literature. Diabet Med 2015;32:1134-42. [PMID: 26096918]

62. Garg SK, Polsky S, Shah VN. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2015 Feb;17 Suppl 1:S119-33. [PMID: 25679422]

63. Shah RB, Patel M, Maahs DM, Shah VN. Insulin delivery methods: Past, present and future. Int J Pharm Investig. 2016 Jan-Mar;6(1):1-9. [PMID: 27014614]

64. Gupta N, Bhadada SK, Shah VN, Mattoo SK. Psychological Aspects Related to Diabetes Mellitus. J Diabetes Res. 2016;2016:7276403. [PMID: 26770989]

65. Gallo T, Shah VN. An Unusual Cause of Recurrent Diabetes Ketoacidosis in Type 1 Diabetes. Am J Med. 2016 Aug;129(8):e139-40. [PMID:27012856] **

66. Dailey G, Ahmad A, Polsky S, Shah V. A novel option for prandial insulin therapy: inhaled insulin. Postgrad Med. 2016 Nov;128(8):839-847. [PMID: 27580306].

67. Unnikrishnan R, Shah VN, Mohan V. Challenges in diagnosis and management of diabetes in the young. Clin Diabetes Endocrinol. 2016 Nov 10;2:18. doi: 10.1186/s40842-016-0036-6. [PMID:28702252]

68. Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peter AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW. REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in well-controlled adults with type 1 diabetes. Diabetes Care. 2017 Apr;40(4):538-545. [PMID:28209654]

69. Haymond MW, DuBose SN, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, Newswanger B, Beck RW; T1D Exchange Mini-dose Glucagon Study Group. Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults with Type 1 Diabetes. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2994-3001. [PMID: 28591776]

70. Shah VN, Harrall KK, Shah CS, Gallo TL, Joshee P, Snell-Bergeon JK, Kohrt WM. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int. 2017 Sep;28(9):2601-2610. [PMID: 28580510]

71. Garg SK, Shah VN, Akturk HK, Beatson C, Snell-Bergeon JK. Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management. Diabetes Ther. 2017 Aug;8(4):811-819. [PMID:28555339]

72. Bally L, Thabit H, Tauschmann M, Allen JM, Hartnell S, Wilinska ME, Exall J, Huegel V, Sibayan J, Borgman S, Cheng P, Blackburn M, Lawton J, Elleri D, Leelarathna L, Acerini CL, Campbell F, Shah VN, Criego A, Evans ML, Dunger DB, Kollman C, Bergenstal RM, Hovorka R. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. BMJ Open. 2017 Jul 13;7(7):e016738. doi: 10.1136/bmjopen-2017-016738. [PMID:28710224]

73. Shah VN, Gallo TL, Marker M, Snell-Bergeon JK. Glycemic Control With Early Initiation of Continuous Glucose Monitoring System in Adults With Recently Diagnosed Type 1A Diabetes. J Diabetes Sci Technol. 2017 Jun 1:1932296817713221. doi: 10.1177/1932296817713221. [PMID: 28660789]

74. Aleppo G, Calhoun P, Foster NC, Maahs DM, Shah VN, Miller KM, T1D Exchange Clinic Network. Reported gastroparesis in adults with type 1 diabetes from the T1D Exchange clinic registry. J Diabetes Complications. 2017;31:1669-73 [PMID: 28989086 ]

75. Akturk HK, Shah VN. Severe Hypoglycemia in Adults with Type 1 Diabetes After Switching to Insulin Degludec. J Diabetes Sci Technol. 2018 May;12(3):733-734.[PMID: 29183157] * *

76. Shah VN, Sippl R, Joshee P, Pyle L, Kohrt WM, Schauer IE, Snell-Bergeon JK. Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int. 2018 Mar;29(3):733-739. [PMID: 29290026]

77. Shah VN. Complications with Insulin Pump Therapy vs Insulin Injection Therapy. JAMA. 2018 Feb 6;319(5):502-503. [PMID: 29411027]

78. Shah VN, Wu M, Foster N, Dhaliwal R, Mukaddam MA. Severe hypoglycemia is associated with high risk for falls in adults with type 1 diabetes. Arch Osteoporos. 2018 Jun 12;13(1):66. [PMID: 29892791]

79. Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM, Foster NC, Peters AL, Levy CJ, Shah VN, Beck RW. Diabetes technology use among pregnant and non-pregnant women with T1D in the T1D Exchange. Diabetes Technol Ther. 2018 Aug;20(8):517-523. [PMID: 29990438]

80. Kaur H, Joshee P, Franquemont S, Baumgartner A, Thurston J, Pyle L, Nadeau KJ, Shah VN. Bone mineral content and bone density is lower in adolescent with type 1 diabetes: A brief report from the RESISTANT and EMERALD studies. J Diabetes Complications. 2018 Oct;32(10):931-933. [PMID: 29980432] **

81. Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technol Ther. 2018 Jun;20(6):428-433.[PMID: 29923775]

82. Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018 Jun; 20(6):395-402. [PMID: 29901421]

83. Shah VN, Carpenter RD, Ferguson VL, Schwartz AV. Bone health in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):231-236. [PMID: 29794498]

84. Bjornstad P, Maahs DM, Roncal CA, Snell-Bergeon JK, Shah VN, Milagres T, Ellis SL, Hatch M, Chung LT, Rewers MJ, Garg S, Cherney DZ, Pyle L, Nadeau KJ, Johnson RJ. Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes. Diabetes Obes Metab. 2018 Jul;20(7):1776-1780. [PMID: 29498467] **

85. Shah VN, Wu M, Polsky S, Snell-Bergeon JK, Sherr JL, Cengiz E, DiMeglio LA, Pop-Busui R, Mizokami-Stout K, Foster NC, Beck RW. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry. J Diabetes Complications. 2018 Oct;32(10):961-965.[PMID: 30121205]

86. Dhaliwal R, Boyle C, Al Mukaddan M, Weinstock RS, Rickels MR, Shah VN, DiMeglio LA. Determinants of fractures in adults with type 1 diabetes in the USA: Results from the T1D Exchange clinic registry. J Diabetes Complications. 2018 Nov;32(11):1006-1011 [PMID: 30220582].

87. Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam11 Consortium. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018 Oct 13;392(10155):1321-1329. [PMID 30292578]

88. Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. J Clin Invest. 2018 May 1;128(5):1888-1902. [PMID: 29438107]

89. Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM, Foster NC, Peters AL, Levy CJ, Shah VN, Beck RW. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange. Diabetes Technol Ther. 2018 Aug;20(8):517-523. [PMID: 29990438]

90. Akturk HK, Taylor D, Camsari U, Rewers A, Kinney G, Shah VN. Association between cannabis use and risk for diabetic ketoacidosis in adults with type 1 diabetes. JAMA Intern Med. 2019 Jan 1;179(1):115-118. [PMID: 30398521] **

91. Mulinacci G, Alonso GT, Snell-Bergeon JK, Shah VN. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes. Diabetes Technol Ther. 2019 Jan;21(1):6-10. [PMID: 30575413] **

92. Shah VN, Joshee P, Sippl R, Pyle L, Vigers T, Carpenter D, Kohrt W, Snell-Bergeon JK. Type 1 diabetes onset at young age is associated with compromised bone quality. Bone. 2019 Jun;123:260-264. [PMID: 30936041]

93. Shah VN, DuBose SN, Li Z, Beck RW, Petesrs AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J. Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364. [PMID: 31127824]

94. Camsari UM, Akturk HK, Taylor DD, Kahramangil D, Shah VN. Unhealthy Cannabis Use among Recreational and Medical Cannabis Users with Type 1 Diabetes. Accepted for publication in Canadian Journal of Addiction, May 2019. **

95. Garg SK, Shah V. Closed-loop delivery systems for patients with diabetes. Lancet Digital Health 2019; 1: PE2-E3. DOI:(19)30007-X

96. Dovc K, Boughton C, Tauschmann M, Thabit H, Bally L, Allen JM, Acerini CL, Arnolds S, de Beaufort C, Bergenstal RM, Campbell F, Criego A, Dunger DB, Elleri D, Evans ML, Fröhlich-Reiterer E, Hofer S, Kapellen T, Leelarathna L, Pieber TR, Rami-Merhar B, Shah VN, Sibayan J, Wilinska ME, Hovorka R; APCam11, AP@Home, and KidsAP Consortia. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery. Diabetes Care. 2019 Jul;42(7):1344-1347. [PMID: 31221700]

97. Kaur H, Schneider N, Pyle L, Campbell K, Akturk HKK, Shah VN. Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis. Diabetes Technol Ther. 2019 Jul 26. doi: 10.1089/dia.2019.0254. [PMID: 31347928]

98. Shah VN. Letter to Editor in response to article published by Leanza et al. Bone 2019; 127:674. [PMID: 31445664]

99. Carlson AL, Kanapka LG, Miller KM, Ahmann AJ, Chaytor NS, Fox DS, Kiblinger L, Kruger D, Levy CJ, Peters AL, Rickels MR, Salam M, Shah VN, Young LA, Kudva YC, Pratley R. Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study. Diabetes Sci Technol. 2019 Dec 21:1932296819894974. [PMID: 31867988]

100. Kinney GL, Akturk HK, Taylor DD, Foster NC, Shah VN. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry. Diabetes Care. 2020 Jan;43(1):247-249. [PMID: 31628116] **

101. Halper-Stromberg E, Gallo T, Champakanath A, Taki I, Rewers M, Snell-Bergeon J, Frohnert BI, Shah VN. Bone Mineral Density across the Life-Span in Patients with Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Nov 2. pii: dgz153. doi: 10.1210/clinem/dgz153. [Epub ahead of print] [PMID: 31676897] **

102. Mizokami-Stout K, Li Z, Shah VN, Aleppo G, McGill J, Pratley R, Toschi E, Ang L, Pop-Busui R. Contemporary prevalence of diabetic neuropathy in type 1 diabetes: Findings from the T1D Exchange. Diabetes Care. 2019 [In Press]

103. Garg S, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Mukherjee B, Shah VN. Efficacy and safety of insulin aspart biosimilar SAR341402 versus originator insulin aspart in people with diabetes treated for 26 weeks with multiple daily injections in combination with insulin glargine: A randomized, open-label trial (GEMELLI 1). Diabetes Technol Ther. 2019 Dec 5. doi: 10.1089/dia.2019.0382. [PMID: 31804851]

104. Shah VN, Snell-Bergeon JK. Fracture risk in type 1 diabetes: Think beyond bone mineral density. J Diabetes Complications. 2019 Nov;33(11):107411. [PMID: 31451334]

105. DuBose SN, Li Z, Sherr JL, Beck RW, Tamborlane WV, Shah VN. Effect of exercise and meals on continuous glucose monitor data in healthy individuals without diabetes. J Diabetes Sci Technol. 2020 Feb 17:1932296820905904. PMID: 32064911

106. Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, Crandall J, Bacha F, Nadeau K, Libman I, Hiers P, Mizokami-Stout K, DiMeglio LA, Sherr J, Pratley R, Agarwal S, Snell-Bergeon J, Cengiz E, Polsky S, Mehta SN; T1D Exchange Registry. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry. J Clin Endocrinol Metab. 2020 May 1;105(5):e2032-8. PMID: 31955209

107. Shah VN, Forlenza GP. Suicide via Intentional Insulin Overdose Through First Commercial Hybrid Closed-Loop. J Diabetes Sci Technol. 2020 May;14(3):687-688. PMID: 32141325

108. Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Miossec P, Mukherjee B, Shah VN. Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial. Diabetes Technol Ther. 2020 Jul;22(7):516-526. PMID: 32068436

109. Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Miossec P, Mukherjee B, Shah VN. Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1). Diabetes Technol Ther. 2020 Feb;22(2):85-95. PMID: 31804851

110. Leelarathna L, Thabit H, Willinska ME, Bally L, Mader JK, Arnolds S, Benesch C, Pieber TR, Shah VN, Carlson AL, Bergenstal RM, Evans ML, Hovorka R; AP@home04 and APCam11 consortia. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care. 2020 Mar;43(3):e38-e39. PMID: 31949086

111. Rickels MR, Evans-Molina C, Bahnson HT, Ylescupidez A, Nadeau KJ, Hao W, Clements MA, Sherr JL, Pratley RE, Hannon TS, Shah VN, Miller KM, Greenbaum CJ; T1D Exchange β-Cell Function Study Group. High residual C-peptide likely contributes to glycemic control in type 1 diabetes. J Clin Invest. 2020 Apr 1;130(4):1850-1862. PMID: 31895699

112. Sherk VD, Schauer I, Shah VN. Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo. Curr Osteoporos Rep. 2020 Aug;18(4):371-377. PMID: 32504189 **

113. Pratley RE, Kanapka LG, Rickels MR, Ahmann A, Aleppo G, Beck R, Bhargava A, Bode BW, Carlson A, Chaytor NS, Fox DS, Goland R, Hirsch IB, Kruger D, Kudva YC, Levy C, McGill JB, Peters A, Philipson L, Philis-Tsimikas A, Pop-Busui R, Shah VN, Thompson M, Vendrame F, Verdejo A, Weinstock RS, Young L, Miller KM; Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 Jun 16;323(23):2397-2406. PMID: 32543682

114. Agarwal S, Kanapka LG, Raymond JK, Walker A, Gerard-Gonzalez A, Kruger D, Redondo MJ, Rickels MR, Shah VN, Butler A, Gonzalez J, Verdejo AS, Gal RL, Willi S, Long JA. Racial-Ethnic Inequity in Young Adults with Type 1 Diabetes. J Clin Endocrinol Metab. 2020 May 8:dgaa236. doi: 10.1210/clinem/dgaa236. Online ahead of print. PMID: 32382736

115. Casu A, Kanapka LG, Foster NC, Hirsch IB, Laffel LM, Shah VN, DeSalvo DJ, Lyons SK, Vendrame F, Aleppo G, Mastrandrea LD, Pratley RE, Rickels MR, Peters AL; T1D Exchange Clinic Network. Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med. 2020 Apr 30. doi: 10.1111/dme.14314. Online ahead of print. PMID: 32353892

116. Shah VN, Grimsmann JM, Foster NC, Dost A, Miller KM, Pavel M, Weinstock RS, Karges W, Maahs DM, Holl RW. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries. Diabetes Obes Metab. 2020 Sep;22(9):1577-1585. PMID: 32329127

117. Eckert AJ, Mader JK, Altmeier M, Mühldorfer S, Gillessen A, Dallmeier D, Shah VN, Heyer C, Hartmann B, Holl RW. Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry. J Diabetes Complications. 2020 Oct;34(10):107664. PMID: 32624333

118. Champakanath A, Keshawarz A, Pyle L, Snell-Bergeon JK, Shah VN. Fracture risk assessment (FRAX) without BMD and risk of major osteoporotic fractures in adults with type 1 diabetes. Bone. 2020 Aug 24:115614. doi: 10.1016/j.bone.2020.115614. Online ahead of print. PMID: 32853853 **

119. Akturk HK, Snell-Bergeon JK, Shah VN. Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes. Diabetes Technol Ther. 2020 Jul 30. doi: 10.1089/dia.2020.0320. Online ahead of print. PMID: 32758007 **

120. Shah VN. Bone mineral density as a surrogate biomarker for fracture risk reduction. Lancet Diabetes Endocrinol 2020; 8: 875. PMID: 33065054

121.

Book Chapters:

1. Bhansali A, Shah VN. Chapter 6: Oral Anti-Diabetic Drugs. Association of Physicians of India (API) Textbook of Medicine 9th Edition, volume -1, 2012 Page no-339-342 []

2. Bhansali A, Shah VN. Genetics of Type 2 Diabetes. In Controversies in Type 2 Diabetes, Editor Prof. B.M.Jairam. Published by Microlab India, 2010.

3. Shah VN, Michels AW, Garg SK. The Use of Medical Technologies for the Reduction of Hypoglycemia in Type 1 Diabetes: Technology for Hypoglycemia Reduction. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 324-328

4. Shah VN. Jain N. Mobile Technologies in Managing Diabetes. In Progress in Medicine 2016 (Medicine update 2016). Pareek KK, Wander GS eds. Jaypee Publishers, Volume 26, P 77-82.

5. Garg SK, Polsky S, Shah VN. New Medications for the Treatment of Diabetes. ATTD 2015 Year book. Also, published as an supplement in Diabetes Technology and Therapeutics [PMID: 25679422]

6. Garg SK, Shah VN. Newer Treatment options in Management of Diabetes. ATTD 2014 Year Book. Also, published as an supplement in Diabetes Technology and Therapeutics [PMID: 24479593]

7. Garg SK, Giordano D, Gallo T, Shah VN. New Medications for the Treatment of Diabetes. ATTD Year Book 2016. Also, published as an supplement in Diabetes Technology and Therapeutics [PMID: 28192022]

8. Shah VN, DiMeglio L. Chapter 23: Sweet Bones: Diabetes Effects on Bone. Basic and Applied Bone Biology, 2nd Edition.

9. Shah VN, Rewers A, Garg SK. Chapter 14: Low Glucose Suspend Systems. In Glucose Monitoring Devices, 1st edition. Editor- Boris Kovatchev.

Other Publications (non peer-reviewed articles and Lay press articles):

1. Shah VN, Toshniwal R, Shah D, Zalawadia H, Shah BK (Editors). A step Towards Rationality. Published by Drug Bank Family, August 15, 2001

2. Shah VN. “Doctor induced disease?” BMJ-SA 2004: 20; 213.

3. Shah VN. Editorial letter. BMJ-SA. 2005:21: 15.

4. Shah VN. “Physician heals thy self”. Indian journal of medical ethics 2005: 2:36.

5. Shah VN. Response letter to “study of clinical profile of malaria at KMC hospital, Attavar, India” published in JCDR July 2007 issue. Journal of clinical and diagnostic research [serial online] 2007 December [cited: 2009 feb 20 ]; 1:581.

6. Shah VN. “Advantages of using mobile Apps technologies to monitor and manage your diabetes”. Diabetes Health Magazine. Apr-May 2015

7. Shah VN. Gallo T. “Advantages of Continuous Glucose Monitoring Systems” Diabetes Health Magazine. Scheduled for July- Aug 2017

8. Shah VN. Diabetes and Fragility Fracture: What Should You Know? Children’s Diabetes Foundation News Notes, Fall 2017

Competitive Scientific Abstracts Published/ Presented:

Manuscripts resulting from students/fellows mentoring work are marked with an asterisk (**)

1. Shah VN. Bhadada S, Bhansali A, Behara A. Influence of age and gender on expression of primary hyperparathyroidism. British Endocrine Society 2011, Birmingham, UK (Endocrine Abstracts (2011) 25 P2. Available at )

2. Shah VN, Cheema BS, Khullar M, Kohli HS, Bhansali A. Gene Polymorphism within AGTR1 is associated with Diabetic Nephropathy in North Indian Type 2 Diabetes Patients”, Oral Presentation at RSSDI Annual Conference, November 4-6, 2011. Received First prize for the abstract.

3. Dubose SN, Maahs DM, Peters AL, Goland RS, Shah V, Bode BW, Miller KM, Beck RW. Better Glycemic Control but Extended Newborn ICU Needs among Pregnant Women with Type 1 Diabetes In T1D Exchange. Diabetes June 2014; 63: Suppl.1 A336.

4. Dhaliwal R, Foster NC, DiMeglio LA, Manseau K, Shah VN, Kittelsrud J, Simmons J, Styner M, Beck R. Osteopenia and Osteoporosis in Adults with Type 1 Diabetes: Results from the T1D Exchange Registry. J Bone Miner Res 2014; 29 (Suppl 1). Available at .

5. Shah VN, Riddelsworth TD, Maahs DM, Miller KM, Beck RW, Garg SK. Does Glucose Control Differ with Insulin Pump Infusion Set Wear Time in Adults with Type 1 Diabetes? Diabetes June 2015; 64: Suppl. 1: A273

6. Ruck D, Shah VN, Runion AM, Snell-Bergeon JK. Factors Affecting Satisfaction with Providers among Adults with Type 1 Diabetes: A Web-Based Survey. Diabetes June 2015; 64: Suppl. 1: A352 **

7. Shah VN, Shah CS, Snell-Bergeon JK. Risk for Bone Fractures in Men and Women with Type 1 Diabetes. Diabetes June 2015; 64: Suppl. 1: A419

8. Shah VN, Strumph P, Banks P, Polsky S, Voelmle M, Garg SK. Improved Glucose Variability and Postprandial Glucose Observed in Phase 2 Study of Sotagliflozin in Adults with Type 1 Diabetes (T1D). Presented at annual meeting of ATTD February 3-6, 2016 Milan, Italy.

9. Shah V, Boyle C, Garg S, Miller K, Beck R for the T1D Exchange Clinic Network. Human Factors Associated with Insulin Pump and Continuous Glucose Monitor Discontinuation among Adults with Type 1 Diabetes (oral presentation). Diabetes Technology & Therapeutics Feb 2, 2016; 18: S1 A18.

10. Shah VN, Pyle L, Struemph T, Sippl R, Snell-Bergeon JK. Factors Affecting Fracture Risk in Type 1 Diabetes: Analysis from the Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes June 2016; 65: Suppl. 1 A318.

11. Shah VN, Pyle L, Joshee P, Ostendorf D, Kohrt WM, Alman AC, Schauer, IE, Snell-Bergeon JK. Trabecular Bone Score Is Lower in Adults with Type 1 Diabetes and Is Related to Visceral and Pericardial Fat but Not Body Mass Index or Subcutaneous Fat. Endocrine Reviews; 38, Issue 3 Supplement, June 2017.

12. Shah VN, Gallo T, Snell-Bergeon JK. Glycemic Control with Early Initiation of Continuous Glucose Monitoring System in Adults with Recently Diagnosed Type 1A Diabetes. Diabetes June 2017; 66: Suppl 1A237-A238.

13. Haymond MW, Dubose S, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, News-Wanger B, Beck RW. Efficacy and Safety of Mini-dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults with Type 1 Diabetes. Diabetes June 2017; 66: Suppl 1A A281.

14. Shah VN, Mengdi Wu, Polsky S, Snell-Bergeon JK for T1D Exchange Clinic Network. Sex Differences in Diabetes Care, Comorbidities and Complications in Adults with Type 1 Diabetes. Diabetes June 2017; 66: Suppl 1A A433.

15. Shah VN, Mengdi Wu, Dhaliwal R, Mukaddam MA. Severe Hypoglycemia Is Associated With Increased Risk For Falls In Adults With Type 1 Diabetes. J Bone Miner Res 2017; 32 (Suppl 1). Available at .

16. Dhaliwal R, Boyle C, Mukaddam MA, Weinstock R, Rickels M, Shah V, DiMeglio L. Fractures in Adults with Type 1 Diabetes: Results from the T1D Exchange Clinic Registry. J Bone Miner Res 2017; 32 (Suppl 1). Available at .

17. Mizokami KR, Boyle CT, Shah VN, Aleppo G, McGill JB, Pratley R, Toschi E, Ang L, Pop-Busui R. Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes- Findings from T1D Exchange. Diabetes June 2018; 67: Suppl.1 A16.

18. Snell-Bergeon JK, Keshawarz A, Kinney GL, Schauer IE, Shah VN, Pyle L. Coronary Artery Calcium Trajectory Predicts Coronary Artery Disease Events- The CACTI Study. Diabetes June 2018; 67: Suppl.1 A119.

19. Shah VN, Joshee P, Sippl RM, Snell-Bergeon JK. Bone and Vascular Health in Postmenopausal Women with Type 1 Diabetes. Diabetes June 2018; 67: Suppl.1 A123.

20. Shah V, Joshee P, Sippl R, Carpenter D, Kohrt W, Snell-Bergeon JK. Bone Mass Geometry and Strength in Postmenopausal Women with Type 1 Diabetes. J Bone Miner Res 2018; 32 (Suppl 1). Available at .

21. Garg S, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Shah VN, Franek E, Sadeharju K, Monchanmp T. Similar Glucose Control, Post-Prandial Glucose Excursions and Safety in People With Diabetes Using SAR341402 OR Insulin Aspart in Combination with Insulin Glargine (Gla-100): GEMELLI 1 Study. 129-LB, American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

22. Leelarathna L, Thabit H, Willinska ME, Bally L, Mader JK, Arnolds S, Pieber TR, Shah VN, Beck RW, Bergenstal RM, Evans ML, Hovorka R on behalf of Ap@home and ApCam 11 consortia. Hybrid closed-loop in adults with Type 1 diabetes: Impact of baseline A1c on glucose outcomes and insulin delivery. American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

23. Mizokami-Stout K, Bailey R, Foster N, Ang L, Aleppo G, Levy CJ, Rickels MR, Shah V, Polsky S, katz M, Nelson B, Carlson A, Vendrame F, Pop-Busui R. Autonomic Neuropathy in Type 1 Diabetes (T1D)- Findings from T1D Exchange. American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

24. Shah VN, Taylor DD, Foster N, Beck RW, Akturk H, Kinney GL. Cannabis Use in Adults with Type 1 Diabetes (T1D) is Associated with Poor Glycemic Control and Increased Risk for Diabetic Ketoacidosis (DKA). American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

25. DuBose SN, Zoey L, Shah VN, Sherr JL, Tamborlene WV, Bergenstal RM, Beck RW. Frequency of Hypoglycemia by Gender in Healthy Individuals without Diabetes-Not so Different after All. American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

26. Agarwal S, Kanapka L, Gerard-Gonzalez A, Raymond J, Walker A, Kruger D, Redondo MJ, Rickels MR, Willi S, Shah VN, Long JA, Butler A, Verdajo AS, Gal RL. Unique Racial-Ethnic Differences Among Poorly Controlled Young Adults with Type 1 Diabetes in the Young Adult Racial Disparities in Type 1 Diabetes (YARDD) Study. American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

27. Maahs DM, Hermann J, Foster N, Dost A, Miller K, Pavel M, Weinstock RS, Karges W, Shah VN, Holl R. Therapeutic Inertia: Gap between Goals and Achievement between the T1DX and DPV Registries. American Diabetes Association 79th annual meeting, June 7-11, 2019 San Francisco, California.

14. CITATIONS

A. Google Scholar: [As of November 1, 2020]

|Citation |2336 |

|H-index |25 |

|i10-index |60 |

B. NCBI profile:

C. Research gate profile:

D. Publon (as reviewer) Profile: [pic]

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download